Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes.

Lai JP, Ho WZ, Zhan GX, Yi Y, Collman RG, Douglas SD.

Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3970-5.

2.

A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes.

Lai JP, Ho WZ, Yang JH, Wang X, Song L, Douglas SD.

J Neuroimmunol. 2002 Jul;128(1-2):101-8.

PMID:
12098517
3.

Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.

Surdo M, Balestra E, Saccomandi P, Di Santo F, Montano M, Di Carlo D, Sarmati L, Aquaro S, Andreoni M, Svicher V, Perno CF, Ceccherini-Silberstein F.

PLoS One. 2013 Jul 9;8(7):e68076. doi: 10.1371/journal.pone.0068076. Print 2013.

4.

Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.

Guo CJ, Li Y, Tian S, Wang X, Douglas SD, Ho WZ.

J Investig Med. 2002 Nov;50(6):435-42. doi: 10.1136/jim-50-06-03.

5.

Substance P enhances HIV-1 replication in latently infected human immune cells.

Li Y, Douglas SD, Song L, Sun S, Ho WZ.

J Neuroimmunol. 2001 Dec 3;121(1-2):67-75.

PMID:
11730941
6.

Alcohol potentiates HIV-1 infection of human blood mononuclear phagocytes.

Wang X, Douglas SD, Metzger DS, Guo CJ, Li Y, O'Brien CP, Song L, Davis-Vogal A, Ho WZ.

Alcohol Clin Exp Res. 2002 Dec;26(12):1880-6.

7.

Extracellular high mobility group box-1 inhibits R5 and X4 HIV-1 strains replication in mononuclear phagocytes without induction of chemokines and cytokines.

Cassetta L, Fortunato O, Adduce L, Rizzi C, Hering J, Rovere-Querini P, Bianchi ME, Alfano M, Poli G.

AIDS. 2009 Mar 13;23(5):567-77. doi: 10.1097/QAD.0b013e328325a47e.

PMID:
19194273
8.
9.

Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity.

Gorry PR, Bristol G, Zack JA, Ritola K, Swanstrom R, Birch CJ, Bell JE, Bannert N, Crawford K, Wang H, Schols D, De Clercq E, Kunstman K, Wolinsky SM, Gabuzda D.

J Virol. 2001 Nov;75(21):10073-89.

10.

Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro.

Wang X, Douglas SD, Lai JP, Tuluc F, Tebas P, Ho WZ.

J Neuroimmune Pharmacol. 2007 Mar;2(1):42-8. Epub 2007 Jan 12.

PMID:
18040825
11.

Potent, broad-spectrum inhibition of human immunodeficiency virus type 1 by the CCR5 monoclonal antibody PRO 140.

Trkola A, Ketas TJ, Nagashima KA, Zhao L, Cilliers T, Morris L, Moore JP, Maddon PJ, Olson WC.

J Virol. 2001 Jan;75(2):579-88.

12.

HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.

Svicher V, Balestra E, Cento V, Sarmati L, Dori L, Vandenbroucke I, D'Arrigo R, Buonomini AR, Van Marck H, Surdo M, Saccomandi P, Mostmans W, Aerssens J, Aquaro S, Stuyver LJ, Andreoni M, Ceccherini-Silberstein F, Perno CF.

Antiviral Res. 2011 Apr;90(1):42-53. doi: 10.1016/j.antiviral.2011.02.005. Epub 2011 Feb 22.

PMID:
21349294
13.

Inhibition of human immunodeficiency virus replication by a dual CCR5/CXCR4 antagonist.

Princen K, Hatse S, Vermeire K, Aquaro S, De Clercq E, Gerlach LO, Rosenkilde M, Schwartz TW, Skerlj R, Bridger G, Schols D.

J Virol. 2004 Dec;78(23):12996-3006.

14.

Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells.

Mengozzi M, De Filippi C, Transidico P, Biswas P, Cota M, Ghezzi S, Vicenzi E, Mantovani A, Sozzani S, Poli G.

Blood. 1999 Mar 15;93(6):1851-7.

16.

Fcgamma receptor-mediated suppression of human immunodeficiency virus type 1 replication in primary human macrophages.

Perez-Bercoff D, David A, Sudry H, Barré-Sinoussi F, Pancino G.

J Virol. 2003 Apr;77(7):4081-94.

17.

Increase of R5 HIV-1 infection and CCR5 expression in T cells treated with high concentrations of CXCR4 antagonists and SDF-1.

Gotoh K, Yoshimori M, Kanbara K, Tamamura H, Kanamoto T, Mochizuki K, Fujii N, Nakashima H.

J Infect Chemother. 2001 Mar;7(1):28-36.

PMID:
11406754
18.

Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.

Ho WZ, Zhu XH, Song L, Lee HR, Cutilli JR, Douglas SD.

AIDS Res Hum Retroviruses. 1995 Apr;11(4):451-9.

PMID:
7632461
19.

Dual-tropic HIV type 1 isolates vary dramatically in their utilization of CCR5 and CXCR4 coreceptors.

Toma J, Whitcomb JM, Petropoulos CJ, Huang W.

AIDS. 2010 Sep 10;24(14):2181-6. doi: 10.1097/QAD.0b013e32833c543f.

PMID:
20639728
20.

Granulocyte-macrophage colony-stimulating factor inhibits HIV-1 replication in monocyte-derived macrophages.

Kedzierska K, Maerz A, Warby T, Jaworowski A, Chan H, Mak J, Sonza S, Lopez A, Crowe S.

AIDS. 2000 Aug 18;14(12):1739-48.

PMID:
10985310

Supplemental Content

Support Center